Therapeutic Asset Ratings

157 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
HUMAN FAECAL MATTER Lymphoma	University Health Network, Toronto	N/A	D (30)
Luspatercept Maligant Granulosa Cell Tumor Of Ovary	University Health Network, Toronto	N/A	D (30)
Marijuana Sleep	University Health Network, Toronto		D (30)
PAN-FGFR TYROSINE KINASE INHIBITOR JNJ-42756493 Theca Steroid-Producing Cell Malignant Tumor Of Ovary, Not Further Specified	University Health Network, Toronto	N/A	D (30)
PAN-FGFR TYROSINE KINASE INHIBITOR JNJ-42756493 Ovarian Cancer	University Health Network, Toronto	N/A	D (26)
Humulin R Intranasal Insulin	University Health Network, Toronto	P1/2	NR (0)
Met-4 Neoplasm	University Health Network, Toronto	P2/3	NR (0)

Showing 151 to 157 of 157 assets

PreviousPage 7 of 7Next